Lung Cancer News and Research

Latest Lung Cancer News and Research

Almac announces study on colorectal pre-malignancies

Almac Diagnostics has announced a major study analysing colorectal polyp tissue samples using its novel Colorectal Cancer DSA microarray.

5 Apr 2007

UT Metroplex institutions to collaborate on biomedical research

Researchers from the three University of Texas campuses in the Dallas-Fort Worth metropolitan area are combining their expertise in biomedical science, engineering and physical sciences on projects aimed at solving real-world medical problems.

5 Apr 2007

Inhaled corticosteroids deserve further consideration for lung cancer chemoprevention

Among a group of mostly older male veterans suffering from chronic obstructive pulmonary disease (COPD), an illness that offers a greater susceptibility to lung cancer, researchers found that regular use of high dose inhaled corticosteroids (ICS) lowered the risk of developing lung cancer.

4 Apr 2007

Harvard presents to Motion Picture Association of America on depiction of smoking in movies

Harvard School of Public Health (HSPH) is releasing materials presented to the Motion Picture Association of America (MPAA) in a scientific briefing requested by the MPAA last February 23, 2007 in Hollywood on the health impact of youth smoking and the behavioral influence of films that depict tobacco use.

3 Apr 2007

Optical biopsy finds cancers in first tests on human tissue

In its first laboratory tests on human tissue, a light-based probe built by researchers at Duke University's Pratt School of Engineering almost instantly detected the earliest signs of cancer in cells that line internal organs.

2 Apr 2007

Lack of Olig1 protein in lung tumors may increase risk of death

A study of human lung tumors indicates that lung cancer patients who lack a particular protein may do more poorly than those with normal levels of that same protein.

2 Apr 2007

ESMO explores collaboration to fight cancer on all fronts

Leading figures in the global fight against lung cancer are meeting in the city of Geneva, Switzerland this week to discuss the latest tools for preventing and treating chest malignancies, which kill more than 1.3 million people each year.

2 Apr 2007

Radiofrequency (RF) ablation effective for treating inoperable lung cancer

A minimally invasive procedure known as radiofrequency (RF) ablation is effective for treating lung cancer in patients who are not candidates for surgery, according to a Rhode Island Hospital study published in the April issue of the journal Radiology.

31 Mar 2007

RF ablation used to treat early-stage, inoperable cancer

Lung cancer patients who are not candidates for surgery now have another safe and effective treatment option: radiofrequency (RF) ablation, according to a new study published in the April issue of the journal Radiology.

31 Mar 2007

Annual computed tomography screening identifies a high proportion of patients with early-stage lung cancer

Lung cancer remains the leading cause of cancer death in both men and women, killing more people than breast, prostate and colon cancers combined, according to the American Cancer Society (ACS). According to the study, the estimated cure rate for lung cancer in the absence of screening is approximately 5 percent, but increases significantly when the cancer is diagnosed and treated at its earliest stage.

31 Mar 2007

CT screening regimen finds early-stage lung cancer

Annual computed tomography (CT) screening identifies a high proportion of patients with early-stage lung cancer, according to the latest findings of the NewYork-Presbyterian Hospital/Weill Cornell Medical Center -- led New York Early Lung Cancer Action Project (NY-ELCAP) published in the April issue of the journal Radiology.

29 Mar 2007

Curecumin - potential treatment for lung cancer

Bioponic Phytoceuticals has announced that its Curecumin (a Bioresonant Phytotherapeutic form of Turmeric containing curcumin in a liquid nasal delivery system) may be an important treatment for Lung Cancer.

28 Mar 2007

Blood pressure drug shows potential as lung cancer treatment

A hormone that is important in the control of blood pressure also shrinks lung cancer tumors in mice, suggesting a new way to prevent or treat the deadly cancer, according to scientists at Wake Forest University School of Medicine.

19 Mar 2007

Native American artists use art and storytelling to bring cancer statistics to life

As an internist and health-care economist, Scott Ramsey, M.D., Ph.D., is used to looking at cancer statistics in black and white. Lately, however, he's been seeing them in shades of vibrant red and deep blue.

12 Mar 2007

Inhaled Celecoxib shows new promise for lung cancer treatment

In recent years, Cycloxygenase (COX)-2 has emerged as a therapeutic target for the prevention and treatment of various types of cancers.

6 Mar 2007

Biomarker for lung cancer identified

Researchers from Boston University School of Medicine (BUSM) have identified a gene expression marker that distinguishes smokers with lung cancer from smokers without the disease. The findings, reported in the March 1, 2007 advanced on-line edition of Nature Medicine, may have immediate clinical relevance and public health impact.

5 Mar 2007

University of Bristol to create new medical research centre

The University of Bristol has been awarded £2.7 million by the Medical Research Council (MRC) to create a new research centre which will apply knowledge from genetic analyses to large-scale studies of the health of the population. These investigations will aim to find the factors that are causing disease, which can then be influenced to reduce risk.

4 Mar 2007

Exposure to diesel exhaust during commutes poses a serious public health risk

The Boston-based environmental research group reported today that even though we spend only a tiny portion of our day commuting, it's during the commute that we receive more than half our overall exposure to deadly fine particle pollution.

28 Feb 2007

Stimuvax investigational lung cancer vaccine phase III study starts

Merck KGaA today announced that the first patient has been enrolled in its global Phase III clinical study, START (Stimulating Targeted Antigenic Responses To NSCLC), assessing the efficacy and safety of Stimuvax (BLP25 liposome vaccine) as a potential treatment for patients with unresectable stage III non-small cell lung cancer (NSCLC).

26 Feb 2007

Publication of the National Mesothelioma Framework

People with a chest cancer related to exposure to asbestos will receive a boost today, as a new framework for improving their care is launched by Britain's Health Minister Rosie Winterton.

From Asthma + Lung UK 26 Feb 2007